Petra Munda
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center.
Journal: Scientific reports
Published: February 28, 2024
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.
Journal: JHEP reports : innovation in hepatology
Published: February 28, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center.
Journal: United European gastroenterology journal
Published: November 27, 2022
Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network-A Competing Risk Analysis.
Journal: Journal of clinical medicine
Published: May 12, 2022
SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 22, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.
Journal: Nature communications
Published: February 05, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.
Journal: Alimentary pharmacology & therapeutics
Published: January 19, 2022
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.
Journal: United European gastroenterology journal
Published: July 13, 2021
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Journal: Hepatology international
Published: January 28, 2021
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity.
Journal: Hepatobiliary surgery and nutrition
Published: November 04, 2020
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.
Journal: Wiener klinische Wochenschrift
Published: May 22, 2020
Prevalence of anti-Hepatitis E antibodies and impact on disease severity in non-alcoholic fatty liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 02, 2020
Last Updated: 09/26/2026